373
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Usefulness of combined treatment with continuous administration of tirapazamine and mild temperature hyperthermia in γ-ray irradiation in terms of local tumour response and lung metastatic potential

, , , , , , & show all
Pages 636-644 | Received 12 Apr 2012, Accepted 17 Jul 2012, Published online: 04 Sep 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Michael R. Horsman. (2016) Realistic biological approaches for improving thermoradiotherapy. International Journal of Hyperthermia 32:1, pages 14-22.
Read now
Michael R. Horsman. (2015) Therapeutic potential of using the vascular disrupting agent OXi4503 to enhance mild temperature thermoradiation. International Journal of Hyperthermia 31:5, pages 453-459.
Read now

Articles from other publishers (2)

Yue Li, Long Zhao & Xiao-Feng Li. (2021) Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy. Frontiers in Oncology 11.
Crossref
Shin-ichiro Masunaga, Yu Sanada, Keizo Tano, Yoshinori Sakurai, Hiroki Tanaka, Takushi Takata, Minoru Suzuki & Koji Ono. (2020) An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness. Journal of Radiation Research 61:6, pages 876-885.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.